SC 13GVNDACIK 0001347178

Vanda Pharmaceuticals Inc.

Name: SEC EDGAR filing 0002052113-26-001132
Creator: Vanda Pharmaceuticals Inc.
License: https://www.usa.gov/government-works

5%+ passive stake (SC 13G) filed October 27, 2026.

Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent.

Open the filing on SEC.gov

New to the SC 13G? What it is and how to read one

Filing facts

Accession number: 0002052113-26-001132
Filer: Vanda Pharmaceuticals Inc.
Ticker: VNDA
CIK: 0001347178
Form type: SC 13G
Form description: 5%+ passive stake
Filed at: October 27, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: October 27, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1347178/000205211326001132/0002052113-26-001132-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Vanda Pharmaceuticals Inc. (0001347178) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0002052113-26-001132.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.